Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending July 10, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding their interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on share transaction details rather than financial performance metrics.
Material Changes
The filing details the acquisition of Ordinary Shares by six individuals through the Company's ShareReward Plan on July 6, 2006. The shares were purchased at a price of GBP 15.26 per Ordinary Share under the Dividend Reinvestment element of the Plan. The specific acquisitions were:
- Mr J S Heslop: 8 Ordinary Shares
- Mr R Bondy: 8 Ordinary Shares
- Mr D Learmouth: 8 Ordinary Shares
- Dr D Pulman: 5 Ordinary Shares
- Mr C Viehbacher: 2 Ordinary Shares
- Mr A P Witty: 8 Ordinary Shares
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is a regulatory disclosure of insider share purchases in accordance with Disclosure Rules 3.1.4R(1)(a) and 3.1.4R(1)(b).
Key Facts for Investor Verification
- Transaction Date: July 6, 2006
- Share Price: GBP 15.26 per Ordinary Share
- Plan Type: ShareReward Plan (Dividend Reinvestment element)
- Total Shares Acquired by Listed Individuals: 39 Ordinary Shares
- Notification Date: July 7, 2006